NIH Center for Regenerative Medicine

The NIH Center for Regenerative Medicine (NIH CRM), funded by the NIH Common Fund, is a federal agency dedicated to providing infrastructure to support and accelerate the development of stem cell-based technologies to clinical maturity. In addition, the NIH CRM is working to create broadly available, standardized resources for stem cell research. The Center also supports the production of induced pluripotent stem cells (iPSCs) for a variety of patient populations and the derivation or isolation of other types of stem cells. The Center also provides a range of adult stem cell and progenitor cell populations as well as the protocols and standard operating procedures (SOPs) for their derivation, cultivation and differentiation. The Center also provides services and information to internal and external NIH research communities to support the use of stem cell technologies for therapeutic and screening purposes. The Center maintains national and international collaborations - including with governments, research institutions and commercial organizations - to ensure that stem cell technology efforts are coordinated and that standardized guidelines are in place to minimize barriers to the advancement of these technologies.